David Daily – Trademark Portfolio

Entity Type: 01

David Daily holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 34 (Smokers Articles) — 6 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include STAX, UPLINE, GRAVITRON, and PT STRAPZ. The owner is based in Austin, TX.

3003 Kinney Ave

Austin, TX 78704

7 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

PT STRAPZ
PT STRAPZ
Registered 2024
CIRCUIT
CIRCUIT
Abandoned 2017
GRAVITRON
GRAVITRON
Registered 2016
UPLINE
UPLINE
Registered 2016
STAX
STAX
Registered 2016
GRAV
GRAV
Cancelled 2015

Trademark Classifications

David Daily's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

34
Smokers Articles (6 filings)

Tobacco; smokers articles; matches

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does David Daily have?

David Daily has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned, 1 cancelled.

What trademark classes does David Daily file in?

David Daily files trademarks across 2 Nice Classification classes. The most active classes are Class 34 (Smokers Articles), Class 10 (Medical Apparatus). Class 34 covers tobacco; smokers articles; matches.

What are David Daily's most well-known trademarks?

David Daily's registered trademark portfolio includes well-known marks such as STAX, UPLINE, GRAVITRON, and PT STRAPZ. These are among 4 currently registered trademarks in the portfolio.

What is David Daily's trademark registration success rate?

David Daily has a 57% trademark registration rate, with 4 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.